## Abstract A series of novel 4__β__‐[(4‐substituted)‐1,2,3‐triazol‐1‐yl]podophyllotoxin derivatives were synthesized by employing Cu^I^‐catalyzed click chemistry and evaluated for their anticancer activity against a panel of seven human cancer cell lines (HT‐29, HCT‐15, 502713, HOP‐62, A‐549, MCF‐
Design, Synthesis, and Biological Testing of 4β-[(4-Substituted)-1,2,3-triazol-1-yl]podophyllotoxin Analogues as Antitumor Agents
✍ Scribed by Pitta B. Reddy; David V. Paul; Satyam K. Agrawal; Ajit K. Saxena; Halmuthur M. S. Kumar; Ghulam N. Qazi
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 495 KB
- Volume
- 341
- Category
- Article
- ISSN
- 0365-6233
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A series of 4β‐[(4‐substituted)‐1,2,3‐triazol‐1‐yl]podophyllotoxin analogues have been synthesized with high regio‐selectivity by employing copper(I)‐catalyzed 1,3‐dipolar cycloaddition of 1‐O‐propargyl monosaccharides with C4β‐azido podophyllotoxin and C4β‐azido‐4′‐O‐demethyl podophyllotoxin. All the compounds were evaluated for their anticancer activity against a panel of six human cancer cell lines. Among these, 4′‐O‐demethyl podophyllotoxin congeners are showing promising anticancer activity mainly against HCT‐15 (colon) and DU‐145 (prostate) cells.
📜 SIMILAR VOLUMES